|
SGMT Sagimet Biosciences Inc 1400118 |
| Balance Sheet |
|
Current Assets
|
$107,716,000.00 |
|
Assets
|
$107,755,000.00 |
|
Current Liabilities
|
$5,297,000.00 |
|
Liabilities
|
$7,180,000.00 |
|
Equity
|
$102,458,000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-8,611,000.00 |
|
Investing Cash Flow
|
$10,216,000.00 |
| Market Analysis |
Market Cap
|
$431,959,040.00 |
|
Price
|
$6.68 |
|
PB
|
3.15 |
|
EPS
|
-0.33 |
|
PS
|
215.98 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:27 |
|
| Apr |
May |
Jun |
| 2026-03-11 |
-0.29 |
|
|
2026-05-12 |
-0.33 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.32 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.40 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SGMT documents filed with the SEC.
SGMT Filings
Clear
